Christine Kanz
Europe Guide 2024
Band 2 : Intellectual Property: Patent Litigation
Email address
[email protected]Contact number
+49 211 550 220Share profile
Band 2
About
Provided by Christine Kanz
Practice Areas
Patents
Career
Christine Kanz has worked as an attorney since 1998. Although she has primarily focused on international patent litigation in the areas of pharmaceuticals, biotechnology and chemistry, she has also handled numerous cases in the areas of medical devices, mechanics and consumer products.
Much of her work involves cross-border litigation with the result that she is highly experienced in planning and coordinating such cases.
After attending the Max Planck Institute for Intellectual Property, Competition and Tax Law in Munich as an auditing student, she obtained her PhD in trademark law in 2002 at the University of Düsseldorf.
Christine regularly publishes on patent law matters and speaks at conferences on patent law issues. She is also a visiting lecturer at the Hagen Law School.
Professional Memberships
American Intellectual Property Law Association (AIPLA)
International Association for the Protection of Intellectual Property (AIPPI)
European Patent Lawyers Association (EPLAW)
German Association for the Protection of Intellectual Property (GRUR)
Intellectual Property Owners Association (IPO)
Licensing Executives Society (LES)
Association of Intellectual Property Experts (VPP)
Publications
Kanz/Gerhardt: What are the risks of second medical use and dosing regimes in pharmaceutical patenting?, Pharmaceutical Patent Analyst, Volume 3, Issue 5, September 2014, p. 481 ff.
Kanz/Lunze: Your Guide to IP issues in Germany, MIP IP Focus Life Sciences, 7th edition 2009, p. 48ff.
Kanz in: Drafting Agreements in the Biotechnology and Pharmaceuticals Industries, Oxford University Press, 2009
Kanz, in: Gewerblicher Rechtsschutz – Urheberrecht – Medienrecht, Kommentar, Carl Heymanns Verlag 2008 (Patentrecht, Mitautor)
Kanz (Mitautorin), Verfahrensrecht und Besonderheiten des Prozessrechts, Berlin Verlag 2007
Kanz, Recent developments in German jurisdiction regarding damages following patent infringement, Pharmaceutical Law Insight, October 2006, Vol. 2, Number 9, p. 17
Kanz/Kasper, Management of US Discovery in Continental Europe: A Practice Report from Germany in The IP Litigator, issue September/October 2005
Kanz, Schutz von Medizinprodukten durch technische Schutzrechte, in: Anhalt/Dieners, Handbuch des Medizinprodukterechts, 2003
Kanz, Zum Kennzeichenrecht im Internet, Düsseldorf 2002
Kanz, Haftungsrechtliche Aspekte von Fahrerassistenzsystemen, ZfAW 2002, 38 ff.
Kanz, How to Collect Evidence in Europe: Proceedings in Germany, Italy and France, and U.S. Discovery in Europe, BNA International, Vol. 20, number 1, p. 20.
Chambers Review
Europe
Christine Kanz ascends in the rankings due to strong market recognition for her notable patent litigation practice. She is particularly popular with life sciences corporations, which she represents in both claimant and defendant patent disputes.
Strengths
Provided by Chambers
"Christine Kanz is very impressive. She is extremely organised and efficient, tackles all issues in details and sees the big picture as to what is important for the company."
"Her analysis is reliable; she takes the lead and thinks about issues from different angles. Christine is a very communicative and excellent lawyer."
"She is a wonderful and great litigator."
"Christine Kanz is very renowned for her work in the pharma and biotech sectors."
"Christine Kanz is very impressive. She is extremely organised and efficient, tackles all issues in details and sees the big picture as to what is important for the company."
"Her analysis is reliable; she takes the lead and thinks about issues from different angles. Christine is a very communicative and excellent lawyer."
"She is a wonderful and great litigator."
"Christine Kanz is very renowned for her work in the pharma and biotech sectors."